EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, BPTH: Bio-Path Holdings

05 Dec 2025
LAST:

0.0860

CHANGE:
 0.01		OPEN:
0.0730		HIGH:
0.0860		ASK:
0.0000		VOLUME:
3.2K
CHG(%):
17.81		PREV:
0.0730		LOW:
0.0730		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Dec 250.07300.08600.07300.08603.2K
04 Dec 250.08140.08140.07300.07306.7K
03 Dec 250.07300.08140.07300.073018.1K
02 Dec 250.07990.07990.07000.07402.2K
01 Dec 250.07000.07300.07000.07007.0K
28 Nov 250.08970.08970.07400.07403.8K
26 Nov 250.07300.07500.07300.073043.3K
25 Nov 250.08980.09000.07470.074713.1K
24 Nov 250.08150.09000.07300.090018.3K
21 Nov 250.07300.08300.07300.0830800

PROFILE

Name:Bio-Path Holdings
About:Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. Its drug delivery and antisense technology is the DNAbilize, a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by the body's enzymes when circulating in vivo, incorporated inside of a lipid bilayer having neutral charge. The company's lead drug candidate is the Prexigebersen (BP1001), which is in phase 2 clinical trial for the treatment of untreated acute myeloid leukemia (AML). It is also developing BP1001-A, which is in phase 1 clinical trial for treatment of solid tumors, including ovarian, endometrial and pancreatic cancer, as well as in preclinical trial to treat obesity and related metabolic diseases; Liposomal Bcl-2 (BP1002), which is in phase 1 clinical trial to treat refractory/relapsed lymphoma and refractory/relapsed chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003), which is preclinical trial for the treatment of pancreatic cancer, non-small cell lung cancer, and AML. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.
Sector:Healthcare
Industry:Biotechnology
Address:4710 Bellaire Boulevard, Bellaire, TX, United States, 77401
Website:https://www.biopathholdings.com
CUSIP:09057N300
CIK:0001133818
ISIN:US09057N3008
FIGI:BBG000PQXTT3

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.0814.4%
MA10:0.0811.5%
MA20:0.086.2%
MA50:0.089.1%
MA100:0.1013.4%
MA200:0.1356.2%
STO9:80.00 
STO14:58.18
RSI14:42.94
WPR14:-20.00 
ATR:0.01 
Week High:0.094.3%
Week Low:0.0722.9%
Month High:0.1016.2%
Month Low:0.0756.2%
Volatility:47.55